Charis L. Himeda

1.3k total citations
25 papers, 995 citations indexed

About

Charis L. Himeda is a scholar working on Molecular Biology, Genetics and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Charis L. Himeda has authored 25 papers receiving a total of 995 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 11 papers in Genetics and 5 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Charis L. Himeda's work include Muscle Physiology and Disorders (19 papers), Virus-based gene therapy research (5 papers) and CRISPR and Genetic Engineering (5 papers). Charis L. Himeda is often cited by papers focused on Muscle Physiology and Disorders (19 papers), Virus-based gene therapy research (5 papers) and CRISPR and Genetic Engineering (5 papers). Charis L. Himeda collaborates with scholars based in United States, France and Russia. Charis L. Himeda's co-authors include Peter L. Jones, Takako I. Jones, Stephen D. Hauschka, Jeffrey A. Ranish, Leonard Meuse, Mark A. Kay, Phillip W.L. Tai, Jeffrey S. Chamberlain, Michael J. Blankinship and Eric Finn and has published in prestigious journals such as Journal of Biological Chemistry, Molecular and Cellular Biology and Journal of Virology.

In The Last Decade

Charis L. Himeda

24 papers receiving 979 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Charis L. Himeda United States 19 894 318 186 135 64 25 995
Kristin N. Heller United States 14 569 0.6× 180 0.6× 137 0.7× 91 0.7× 60 0.9× 20 644
Carmen Bertoni United States 17 662 0.7× 246 0.8× 51 0.3× 74 0.5× 57 0.9× 27 763
Sofia Benkhelifa‐Ziyyat France 12 657 0.7× 261 0.8× 56 0.3× 280 2.1× 194 3.0× 22 850
Gwladys Gernoux United States 11 458 0.5× 345 1.1× 66 0.4× 165 1.2× 16 0.3× 20 674
Marybeth Camboni United States 11 406 0.5× 166 0.5× 102 0.5× 54 0.4× 38 0.6× 14 478
William Nikovits United States 13 608 0.7× 134 0.4× 126 0.7× 38 0.3× 101 1.6× 15 737
Gaynor Miller United Kingdom 15 380 0.4× 77 0.2× 162 0.9× 52 0.4× 34 0.5× 20 700
Stuart G. Beattie Spain 10 640 0.7× 306 1.0× 93 0.5× 43 0.3× 29 0.5× 16 797
Stephanie Salabarria United States 3 371 0.4× 278 0.9× 56 0.3× 53 0.4× 29 0.5× 5 537
Natee Jearawiriyapaisarn Thailand 13 591 0.7× 116 0.4× 50 0.3× 199 1.5× 29 0.5× 27 685

Countries citing papers authored by Charis L. Himeda

Since Specialization
Citations

This map shows the geographic impact of Charis L. Himeda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charis L. Himeda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charis L. Himeda more than expected).

Fields of papers citing papers by Charis L. Himeda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charis L. Himeda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charis L. Himeda. The network helps show where Charis L. Himeda may publish in the future.

Co-authorship network of co-authors of Charis L. Himeda

This figure shows the co-authorship network connecting the top 25 collaborators of Charis L. Himeda. A scholar is included among the top collaborators of Charis L. Himeda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charis L. Himeda. Charis L. Himeda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Himeda, Charis L., Takako I. Jones, & Peter L. Jones. (2025). All-in-one vectors for epigenetic CRISPR inhibition of DUX4-fl in facioscapulohumeral muscular dystrophy. Molecular Therapy — Methods & Clinical Development. 33(3). 101546–101546.
2.
Himeda, Charis L., Takako I. Jones, & Peter L. Jones. (2024). Have a Little Heart (or Not): Highly Minimized Skeletal Muscle Regulatory Cassettes with Low or No Activity in the Heart. Human Gene Therapy. 35(15-16). 543–554. 2 indexed citations
3.
Himeda, Charis L., Takako I. Jones, & Peter L. Jones. (2020). Targeted epigenetic repression by CRISPR/dSaCas9 suppresses pathogenic DUX4-fl expression in FSHD. Molecular Therapy — Methods & Clinical Development. 20. 298–311. 41 indexed citations
4.
Himeda, Charis L. & Peter L. Jones. (2019). The Genetics and Epigenetics of Facioscapulohumeral Muscular Dystrophy. Annual Review of Genomics and Human Genetics. 20(1). 265–291. 53 indexed citations
5.
Himeda, Charis L., Takako I. Jones, Ching-Man Virbasius, et al.. (2018). Identification of Epigenetic Regulators of DUX4-fl for Targeted Therapy of Facioscapulohumeral Muscular Dystrophy. Molecular Therapy. 26(7). 1797–1807. 33 indexed citations
6.
Jones, Takako I., et al.. (2016). Large family cohorts of lymphoblastoid cells provide a new cellular model for investigating facioscapulohumeral muscular dystrophy. Neuromuscular Disorders. 27(3). 221–238. 18 indexed citations
7.
Himeda, Charis L., Takako I. Jones, & Peter L. Jones. (2016). Scalpel or Straitjacket: CRISPR/Cas9 Approaches for Muscular Dystrophies. Trends in Pharmacological Sciences. 37(4). 249–251. 5 indexed citations
8.
Jones, Takako I., Oliver D. King, Charis L. Himeda, et al.. (2015). Individual epigenetic status of the pathogenic D4Z4 macrosatellite correlates with disease in facioscapulohumeral muscular dystrophy. Clinical Epigenetics. 7(1). 37–37. 59 indexed citations
9.
Himeda, Charis L., Takako I. Jones, & Peter L. Jones. (2015). CRISPR/dCas9-mediated Transcriptional Inhibition Ameliorates the Epigenetic Dysregulation at D4Z4 and Represses DUX4-fl in FSH Muscular Dystrophy. Molecular Therapy. 24(3). 527–535. 80 indexed citations
10.
Himeda, Charis L., Takako I. Jones, & Peter L. Jones. (2014). Facioscapulohumeral Muscular Dystrophy As a Model for Epigenetic Regulation and Disease. Antioxidants and Redox Signaling. 22(16). 1463–1482. 28 indexed citations
11.
Himeda, Charis L., Marietta Barro, & Charles P. Emerson. (2013). Pax3 synergizes with Gli2 and Zic1 in transactivating the Myf5 epaxial somite enhancer. Developmental Biology. 383(1). 7–14. 26 indexed citations
12.
Himeda, Charis L., Phillip W.L. Tai, & Stephen D. Hauschka. (2011). Analysis of Muscle Gene Transcription in Cultured Skeletal Muscle Cells. Methods in molecular biology. 798. 425–443. 2 indexed citations
13.
Tai, Phillip W.L., Katherine Fisher-Aylor, Charis L. Himeda, et al.. (2011). Differentiation and fiber type-specific activity of a muscle creatine kinase intronic enhancer. Skeletal Muscle. 1(1). 25–25. 25 indexed citations
14.
Himeda, Charis L., Xiaolan Chen, & Stephen D. Hauschka. (2010). Design and Testing of Regulatory Cassettes for Optimal Activity in Skeletal and Cardiac Muscles. Methods in molecular biology. 709. 3–19. 35 indexed citations
15.
Himeda, Charis L., Jeffrey A. Ranish, Richard C. M. Pearson, Merlin Crossley, & Stephen D. Hauschka. (2010). KLF3 Regulates Muscle-Specific Gene Expression and Synergizes with Serum Response Factor on KLF Binding Sites. Molecular and Cellular Biology. 30(14). 3430–3443. 50 indexed citations
16.
Himeda, Charis L., Jeffrey A. Ranish, & Stephen D. Hauschka. (2008). Quantitative Proteomic Identification of MAZ as a Transcriptional Regulator of Muscle-Specific Genes in Skeletal and Cardiac Myocytes. Molecular and Cellular Biology. 28(20). 6521–6535. 41 indexed citations
17.
Himeda, Charis L., Phillip W.L. Tai, Eiko Nishiuchi, et al.. (2007). Design of Tissue-specific Regulatory Cassettes for High-level rAAV-mediated Expression in Skeletal and Cardiac Muscle. Molecular Therapy. 15(2). 320–329. 182 indexed citations
18.
Bjornson, Christopher R.R., Kevin Griffin, Gist H. Farr, et al.. (2005). Eomesodermin Is a Localized Maternal Determinant Required for Endoderm Induction in Zebrafish. Developmental Cell. 9(4). 523–533. 71 indexed citations
19.
Himeda, Charis L., Jeffrey A. Ranish, John C. Angello, et al.. (2004). Quantitative Proteomic Identification of Six4 as the Trex-Binding Factor in the Muscle Creatine Kinase Enhancer. Molecular and Cellular Biology. 24(5). 2132–2143. 64 indexed citations
20.
Buskin, Jean N., et al.. (2003). Differences in the Function of Three Conserved E-boxes of the Muscle Creatine Kinase Gene in Cultured Myocytes and in Transgenic Mouse Skeletal and Cardiac Muscle. Journal of Biological Chemistry. 278(47). 46494–46505. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kristin N. Heller Breakdown of academic impact, for papers by Carmen Bertoni Breakdown of academic impact, for papers by Sofia Benkhelifa‐Ziyyat Breakdown of academic impact, for papers by Gwladys Gernoux Breakdown of academic impact, for papers by Marybeth Camboni Breakdown of academic impact, for papers by William Nikovits Breakdown of academic impact, for papers by Gaynor Miller Breakdown of academic impact, for papers by Stuart G. Beattie Breakdown of academic impact, for papers by Stephanie Salabarria Breakdown of academic impact, for papers by Natee Jearawiriyapaisarn
Rankless by CCL
2026